Previous 10 | Next 10 |
Clarivate Completes Restatement of Prior Financial Statements; Comments on 2022 Financial Outlook -- Files Amendments to Form 10-K for 2020 and Form 10-Q's for 2021 -- -- Updates 2022 Financial Outlook -- PR Newswire LONDON , Feb. 3, 2022 /PRNewswire/ --&...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Clarivate To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 30, 2022) - Faruqi & Faruqi, LLP, a leading national securities law fir...
Clarivate Launches New Global Research Report on Managing Academic Publication Credit in a Collaborative World Institute for Scientific Information proposes new Collaborative CNCI indicator Canada NewsWire LONDON , Jan. 26, 2022 /CNW/ -- Clarivate Plc (NY...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Clarivate To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 24, 2022) - Faruqi & Faruqi, LLP, a leading national securities l...
We have identified names that look bearish and may present interesting investing opportunities on the short side. Using technical analysis of the charts of those stocks and appropriate recent actions, we have zeroed in on 2 names. Clarivate Source – TradingView ...
Clarivate Patent Trend Report Shows Increasing Business Focus on Innovation Through Patent Portfolio Spend Global organizations cite patent innovation as key to increasing competitive advantage amidst the pandemic Canada NewsWire LONDON , Jan. 18, 2022 /CNW/ ...
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Clarivate Plc (“Clarivate” or the “Company”) (NASDAQ: CLVT) on behalf of Clarivate stockholders. Our investigation concerns whether...
Clarivate Announces Change in Leadership Structure Canada NewsWire Gordon Samson appointed Chief Product Officer; Mukhtar Ahmed leaving Clarivate LONDON , Jan. 10, 2022 /CNW/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted ...
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report Canada NewsWire Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report ...
Clarivate (NYSE:CLVT) has acquired Patient Connect, a provider of patient engagement solutions that enable the measurement of clinical and commercial outcomes and inform the advancement of healthcare. Patient Connect has a global reach of 834,000 physicians, 600,000 pharmacists and 1,000,000,...
News, Short Squeeze, Breakout and More Instantly...
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence Canada NewsWire Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON , July 30, 2024 /CNW/ -- Cl...
Clarivate Director Richard Roedel to Retire from Board of Directors PR Newswire Valeria Alberola to Succeed as Audit Committee Chair LONDON , July 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelli...
Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners Canada NewsWire Delivering integrated, AI-enabled solutions specifically designed for patent preparation and prosecution LONDON , July 22, 2024 /CNW/ -- Clarivate Plc (NYSE: CLV...